LEADER 02258nam  2200637Ia 450 
001 9910780146303321
005 20230607213825.0
010   $a0-309-17037-0
010   $a1-280-18418-3
010   $a9786610184187
010   $a0-309-56573-1
035   $a(CKB)111069351124296
035   $a(OCoLC)57005524
035   $a(CaPaEBR)ebrary10068398
035   $a(SSID)ssj0000176888
035   $a(PQKBManifestationID)11170154
035   $a(PQKBTitleCode)TC0000176888
035   $a(PQKBWorkID)10206980
035   $a(PQKB)10900597
035   $a(MiAaPQ)EBC3377165
035   $a(Au-PeEL)EBL3377165
035   $a(CaPaEBR)ebr10068398
035   $a(OCoLC)923268733
035   $a(EXLCZ)99111069351124296
100   $a20040120d2001      uy             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt
182   $cc
183   $acr
200 00$aImmunization safety review$b[electronic resource] $ethimerosal-containing vaccines and neurodevelopmental disorders /$fKathleen Stratton, Alicia Gable, and Marie C. McCormick, editors ; Immunization Safety Review Committee, Board on Health Promotion and Disease Prevention, Institute of Medicine
210   $aWashington, D.C. ;$a[Great Britain] $cNational Academy Press$dc2001
215   $a1 online resource (136 p.) 
225 1 $aThe Compass series
300   $aBibliographic Level Mode of Issuance: Monograph
311   $a0-309-07636-6 
320   $aIncludes bibliographical references.
410  0$aCompass series (Washington, D.C.)
606   $aVaccination$xComplications
606   $aDevelopmental disabilities$xEtiology
606   $aOrganomercury compounds$xToxicology
615  0$aVaccination$xComplications.
615  0$aDevelopmental disabilities$xEtiology.
615  0$aOrganomercury compounds$xToxicology.
676   $a614.593
701   $aStratton$b Kathleen R$01462488
701   $aGable$b Alicia$01493804
701   $aMcCormick$b Marie C$01462490
712 02$aInstitute of Medicine (U.S.).$bImmunization Safety Review Committee.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910780146303321
996   $aImmunization safety review$93716987
997   $aUNINA